Abstract:Exposure of Limulus amoebocyte lysate to endotoxin under stirring produced light-reflective particles that appeared to be coagulin polymers. A laser light-scattering particle counter, the PA-200, detected these particles sensitively. The PA-200 detected endotoxin at a concentration as low as 0.00015 EU/ml in 71 min, whereas the minimum endotoxin concentration measured by a turbidimeter, ET-2000, was 0.0005 EU/ml in 138 min. Moreover, PA-200 was much less affected by the presence of colored substances and refra… Show more
“…In the pharmaceut ical industry, the current requirement is for a highly sensitive measurement method that is able to detect 0.1 pg/ml (equivalent to 0.0007 EU/ml) endotoxin for human health [8]. [6,7,13]. Therefore, the end-point methods are mainly used as primary tests for endotoxin contamination in products and the kinetic methods are used for the detection of low levels of endotoxin, for example in clinical treatments [14][15][16].…”
Section: Discussionmentioning
confidence: 99%
“…Recent ly, a laser light-scattering particle-counting method was reported as a new turbidimetric kinetic method for detecting endotoxin with high sensitivity [13,17]. The bioluminescence method using mutant luciferase was effective for rapid and highly sensitive endotoxin detection.…”
The Limulus reaction is an application of the defense mechanism of horseshoe crab for endotoxin detection. Endotoxin is a component of the cell wall in the outer membrane of gram-negative bacteria, and causes fever or shock when it enters the human blood stream. For endotoxin detection, gel formation or turbidity of the coagulation factor chromogen or fluorescence-modified peptide is used. However, these conventional methods have problems with regard to their measurement time or sensitivity. We recently obtained a mutant firefly luciferase that has a luminescence intensity over 10-fold higher than that of the wild type. Therefore, we developed a new endotoxin detection method that combines the Limulus reaction and bioluminescence using mutant luciferase. The new method detects 0.0005EU/ml of endotoxin within 15min.
“…In the pharmaceut ical industry, the current requirement is for a highly sensitive measurement method that is able to detect 0.1 pg/ml (equivalent to 0.0007 EU/ml) endotoxin for human health [8]. [6,7,13]. Therefore, the end-point methods are mainly used as primary tests for endotoxin contamination in products and the kinetic methods are used for the detection of low levels of endotoxin, for example in clinical treatments [14][15][16].…”
Section: Discussionmentioning
confidence: 99%
“…Recent ly, a laser light-scattering particle-counting method was reported as a new turbidimetric kinetic method for detecting endotoxin with high sensitivity [13,17]. The bioluminescence method using mutant luciferase was effective for rapid and highly sensitive endotoxin detection.…”
The Limulus reaction is an application of the defense mechanism of horseshoe crab for endotoxin detection. Endotoxin is a component of the cell wall in the outer membrane of gram-negative bacteria, and causes fever or shock when it enters the human blood stream. For endotoxin detection, gel formation or turbidity of the coagulation factor chromogen or fluorescence-modified peptide is used. However, these conventional methods have problems with regard to their measurement time or sensitivity. We recently obtained a mutant firefly luciferase that has a luminescence intensity over 10-fold higher than that of the wild type. Therefore, we developed a new endotoxin detection method that combines the Limulus reaction and bioluminescence using mutant luciferase. The new method detects 0.0005EU/ml of endotoxin within 15min.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.